Key result
HF is linked to ~21% lower 2-year amputation-free survival after infrainguinal revascularization in CLTI.
Why the study?
Does heart failure worsen amputation-free survival in patients with chronic limb-threatening ischemia undergoing infrainguinal revascularization?
Cohort (n=772)
Yes
Does heart failure worsen amputation-free survival in patients with chronic limb-threatening ischemia undergoing infrainguinal revascularization?
Answers are grounded in this paper and cite their sources.
Heart failure, particularly with reduced ejection fraction, is a robust negative predictor of amputation-free survival in patients with chronic limb-threatening ischemia undergoing infrainguinal revascularization.
OBJECTIVE: We examined the influence of heart failure (HF) on patients with chronic limb-threatening ischemia (CLTI) and the negative predictors of limb and life prognosis among patients with CLTI and HF, the clinical outcomes of patients with CLTI after infrainguinal revascularization were compared. METHODS: Multicenter data of patients who underwent infrainguinal revascularization for CLTI between 2015 and 2022 were analyzed retrospectively. The end point was amputation-free survival (AFS) among patients with HF or without HF. Subgroup analyses among patients with HF were performed grouped by revascularization procedures or ejection fraction (EF) classification: HF with reduced EF (HFrEF) (EF of <40%), HF with mildly reduced EF (HFmrEF) (40% ≤ EF < 50%), and HF with preserved EF (HFpEF) (EF ≥50%). RESULTS: Of the 772 patients included, 186 (24%) had HF. No differences were found in the Wound, Ischemia, foot Infection (WIfI) stage, Global Limb Anatomic Staging System stage, or treatment procedures between the HF and non-HF groups. The 2-year AFS rates of the HF and non-HF groups were 63% ± 2% vs 50% ± 4%, respectively (P < .01). Among the HF group, the AFS of the bypass group was significantly higher than that of the endovascular therapy (EVT) group (59% ± 7% vs 46% ± 5%; P = .04). Then, the AFS rates of the HFpEF, HFmrEF, and HFrEF groups were 61% ± 6%, 50% ± 8%, and 35% ± 7%, respectively (P < .01). Multivariate Cox proportional hazard analyses identified age ≥80 years, nonambulatory status, hypoalbuminemia (<3.5 g/dL), end-stage renal disease, EVT, WIfI stage 4, and HF as negative predictors of AFS among all patients. In the HF group, age ≥80 years, nonambulatory status, EVT, WIfI stage 4, and reduced EF (<40%) were significant negative predictors. CONCLUSIONS: HF is a robust negative predictor of AFS among patients with CLTI who underwent infrainguinal revascularization. HFrEF was a negative predictor of AFS.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2025) conducted a cohort in Chronic limb-threatening ischemia (CLTI) (n=772). Heart failure vs. No heart failure was evaluated on Amputation-free survival (AFS) (p=<.01). Heart failure was associated with significantly lower 2-year amputation-free survival compared to no heart failure in patients with CLTI after infrainguinal revascularization (50% vs 63%; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: